NEXGEL, Inc. (NXGL) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Instruments & Supplies industria. La empresa tiene su sede en Langhorne, PA, United States. El CEO actual es Adam R. Levy.
NXGL tiene fecha de IPO 2021-12-22, 19 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $6.34M.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
